fda compounded glp 1 issued 25 warning letters to telehealth companies for false and misleading claims about GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of Why the FDA is cracking
Description
These products are not FDA-approved drugs
This approach emphasizes: Personalized care plans: Integrating treatment with lifestyle and natural interventions
*for extracare: ExtraCare card required
Initial approval is usually 6 months
But with list prices of roughly $1,000 a month, public and private payers are struggling to keep up with ballooning demand for GLP-1 weight loss drugs and in some cases are eliminating or restricting their coverage as a result
